ACLX
Price
$77.58
Change
+$0.79 (+1.03%)
Updated
Dec 24, 02:00 PM (EDT)
86 days until earnings call
DAWN
Price
$12.67
Change
-$0.02 (-0.16%)
Updated
Dec 24, 02:00 PM (EDT)
76 days until earnings call
Ad is loading...

ACLX vs DAWN

Header iconACLX vs DAWN Comparison
Open Charts ACLX vs DAWNBanner chart's image
Arcellx
Price$77.58
Change+$0.79 (+1.03%)
Volume$29.24K
CapitalizationN/A
Day One Biopharmaceuticals
Price$12.67
Change-$0.02 (-0.16%)
Volume$26.8K
CapitalizationN/A
ACLX vs DAWN Comparison Chart
Loading...
ACLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DAWN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACLX vs. DAWN commentary
Dec 25, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACLX is a Hold and DAWN is a Hold.

Ad is loading...
COMPARISON
Comparison
Dec 25, 2024
Stock price -- (ACLX: $76.79 vs. DAWN: $12.69)
Brand notoriety: ACLX and DAWN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACLX: 58% vs. DAWN: 62%
Market capitalization -- ACLX: $4.15B vs. DAWN: $1.28B
ACLX [@Biotechnology] is valued at $4.15B. DAWN’s [@Biotechnology] market capitalization is $1.28B. The market cap for tickers in the [@Biotechnology] industry ranges from $363.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACLX’s FA Score shows that 0 FA rating(s) are green whileDAWN’s FA Score has 0 green FA rating(s).

  • ACLX’s FA Score: 0 green, 5 red.
  • DAWN’s FA Score: 0 green, 5 red.
According to our system of comparison, DAWN is a better buy in the long-term than ACLX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACLX’s TA Score shows that 4 TA indicator(s) are bullish while DAWN’s TA Score has 4 bullish TA indicator(s).

  • ACLX’s TA Score: 4 bullish, 6 bearish.
  • DAWN’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, DAWN is a better buy in the short-term than ACLX.

Price Growth

ACLX (@Biotechnology) experienced а -7.95% price change this week, while DAWN (@Biotechnology) price change was +0.55% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.99%. For the same industry, the average monthly price growth was -2.01%, and the average quarterly price growth was +3.17%.

Reported Earning Dates

ACLX is expected to report earnings on Mar 20, 2025.

DAWN is expected to report earnings on Mar 10, 2025.

Industries' Descriptions

@Biotechnology (-0.99% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACLX($4.2B) has a higher market cap than DAWN($1.28B). ACLX YTD gains are higher at: 38.360 vs. DAWN (-13.082). ACLX has higher annual earnings (EBITDA): -33.12M vs. DAWN (-210.08M). ACLX (574M) and DAWN (558M) have equal amount of cash in the bank . DAWN has less debt than ACLX: DAWN (2.62M) vs ACLX (65.3M). ACLX has higher revenues than DAWN: ACLX (156M) vs DAWN (102M).
ACLXDAWNACLX / DAWN
Capitalization4.2B1.28B328%
EBITDA-33.12M-210.08M16%
Gain YTD38.360-13.082-293%
P/E RatioN/AN/A-
Revenue156M102M153%
Total Cash574M558M103%
Total Debt65.3M2.62M2,497%
TECHNICAL ANALYSIS
Technical Analysis
ACLXDAWN
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
75%
MACD
ODDS (%)
Bearish Trend 7 days ago
78%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
75%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
72%
Bearish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 26 days ago
84%
Declines
ODDS (%)
Bearish Trend 6 days ago
75%
Bearish Trend 6 days ago
80%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
78%
Aroon
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
81%
View a ticker or compare two or three
Ad is loading...
ACLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DAWN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
BULZ177.987.74
+4.55%
MicroSectors™ Slct FANG Inn 3X Lvgd ETNs
MBCC35.010.15
+0.43%
Monarch Blue Chips Core ETF
AUSF42.250.01
+0.02%
Global X Adaptive US Factor ETF
CADGBP0.55N/A
N/A
Canadian Dollar - United Kingdom Pound
SDCI20.41N/A
N/A
USCF SummerHaven Dyn CmdtyStgy NoK-1 ETF

ACLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACLX has been loosely correlated with BEAM. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ACLX jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACLX
1D Price
Change %
ACLX100%
+1.65%
BEAM - ACLX
49%
Loosely correlated
-1.07%
DNLI - ACLX
48%
Loosely correlated
-3.12%
RCKT - ACLX
48%
Loosely correlated
-1.12%
RCUS - ACLX
47%
Loosely correlated
+2.97%
CRSP - ACLX
47%
Loosely correlated
-0.59%
More